Skip to content
Kither Biotech
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
×
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact

Il Sole 24 Ore

2019-31-Dic Il Sole 24 Ore

La Repubblica Piemonte Economia

2019-15-Lug La Repubblica Piemonte Economia

Private Capital Today

2019-09-Lug Private Capital Today

Finsmes

2019-09-Lug Finsmes

FederFarma

2019-08-Lug FederFarma

BeBeez

2019-08-Lug BeBeez

StartUp Italia

2019-05-Lug StartUp Italia

La Mia Finanza

2019-05-Lug La Mia Finanza

BioSpace

2019-05-Lug BioSpace

Biopharma Dive

2019-05-Lug Biopharma Dive

Recent articles

  • Kither Biotech successfully completes Phase 1 clinical trial of KIT2014, a novel inhaled peptide therapy for respiratory diseases
  • Kither Biotech and Pantherna Therapeutics Announce Strategic Collaboration on Synergistic mRNA and Peptide Therapies for Genetic Lung Diseases
  • Kither Biotech Announces Phase 1 Clinical Study Of KIT2014, A Novel Inhaled Peptide Therapy For Cystic Fibrosis
  • Kither Biotech Announces Appointment of Dr. Dimitrios Goundis to Board of Directors
  • Kither Biotech announces publication of new data in Science Translational Medicine

Dynamic scientific development for a better tomorrow

Contact Us
Kither Biotech
Kither Biotech is a biopharmaceutical company developing signal transduction modulators for the treatment of rare respiratory diseases.
Linkedin Youtube
Menu
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
×
  • Home
  • About Us
    • Company Overview
    • Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Drug development
    • Publications
  • Pipeline
    • KIT2014
    • KITCL27
  • Media
    • Press releases
    • Press coverage
  • Careers
  • Contact
Contact
  • Via Nizza 52, 10126,
    Turin (TO), Italy
  • info@kitherbiotech.com
Useful information
  • Privacy Policy
  • Cookie Policy

KITHER BIOTECH S.R.L. © COPYRIGHT 2021-2025. P. IVA 10615040010. DESIGN BY WEB AGENCY TORINO – WEB BRAND